This is an automatically translated article.
Livran-500 Tablets with the main ingredient is Levofloxacin belonging to the group of parasitic, antiviral, antifungal, anti-infective drugs. To better understand the ingredients, uses and usage of Livran-500 Tablets, please refer to the information in the article below.
1. What is Livran-500 Tablets?
What is Livran 500 tablets ? Livran-500 Tablets is a parasitic and anti-infective drug whose main ingredient is Levofloxacin. This is a product manufactured by M/s Maxtar Bio-Genics circulating in Vietnam.
Livran-500 Tablets have the main ingredients and active ingredients and excipients just enough with the drug content provided by the manufacturer. Livran-500 Tablets are prepared in the form of film-coated tablets and are packaged in boxes.
2. Indications and contraindications Livran-500 Tablets
2.1.Indications Livran-500 Tablets are indicated for use in mild, moderate and severe infections in the elderly:
Acute sinusitis Chronic bronchitis exacerbation Pneumonia Acquired pneumonia in community Skin and skin structure infections Urinary tract infections with or without complications Acute pyelonephritis. 2.2. Contraindications Contraindicated to use Livran-500 Tablets in the following cases:
Patients with hypersensitivity to the drug ingredients Livran-500 Tablets, quinolone antibiotics.
3. Dosage and how to use Livran-500 Tablets
3.1. How to use Each drug and pharmaceutical product manufactured will be prepared in a different form, so the route of drug administration also has different routes. Patients should carefully read the instructions on how to use the drug, do not arbitrarily change the route and dosage of the drug.
3.2. Dosage of Livran-500 Tablets The dosage of Livran-500 Tablets is for reference only, patients need to follow the recommendations and indications of the doctor or pharmacist.
Dosage for adults:
Acute sinusitis: Dose 500 mg/day x 10-14 days. Exacerbation of chronic bronchitis: Dosage 250 - 500 mg/day x 7-10 days. Community-acquired pneumonia: 500 mg dose, 1-2 times a day x 7-14 days. Complicated urinary tract infections including nephritis - pyelonephritis: 250 mg/day x 7-10 days. Skin & soft tissue infections: Dosage 500 mg, 1-2 times a day x 7-14 days. Patients with renal impairment (ClCr <50mL/min) need to reduce the dose. as directed by the doctor.
Dosage of Livran-500 for children: The pharmacokinetics and pharmacodynamics of children are different from those of adults. Therefore, when using the drug for children, it is necessary to consult and carefully consider the doctor.
4. Overdose, missed dose of Livran-500 how to handle?
Overdose of Livran-500: In case of emergency or when the patient overdoses and has dangerous symptoms, the patient should stop using and immediately go to a medical facility for examination and treatment. short time.
Missed dose: If the patient forgets to take a dose of Livran-500, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and take your next dose as usual. Note: Do not double the prescribed dose of Livran-500.
5. Notes before taking Livran-500 Tablets
During the use of Livran-500, patients should pay attention to the following issues:
Pregnancy: Pregnant women using Livran-500 Tablets during pregnancy may cause adverse effects. Bad use causes fetal malformations, miscarriage, ... at any stage of pregnancy, especially in the first trimester. Therefore, the use of Livran-500 Tablets is contraindicated for pregnant women. In cases where it is imperative to use Livran-500 Tablets, it is necessary to consult a specialist doctor before making a decision. Lactation: The active ingredients in Livran-500 Tablets can be excreted in breast milk. Therefore, to ensure the health of the mother, it is recommended to limit the use of Livran-500 Tablets during this period. In fact, there are many drugs that have yet to be identified with effects on nursing mothers. Therefore, if you decide to use it, please read the instructions carefully and consult your doctor, clinical pharmacist.
6. Side effects when using Livran-500 Tablets
During the use of Livran-500 Tablets, some side effects may occur with the following frequency:
Common side effects: Nausea, vomiting, digestive disorders, diarrhea, change in appetite , sleep disturbance, dizziness, dizziness, headache. Rare side effects: Sensitivity to sunlight, musculoskeletal pain, abdominal pain, allergic reactions, vision changes. Very rare side effects: Seizures, chest pain, arrhythmia, mental confusion, restlessness, anxiety, change in urine output, superinfection. Note: This is not a complete list of the side effects associated with Livran 500 Tablets. During the use of Livran-500 Tablets, patients may still experience other side effects that have never been recorded.
Therefore, if there are any other manifestations of side effects when using Livran-500 Tablets not specified in the instructions for use, the patient should stop using and consult a doctor or pharmacist. .
7. Drug interactions
When using two or more drugs at the same time, there may be an interaction that increases or decreases the therapeutic effect, even increases the risk of unwanted effects. Below is information on drug interactions Livran-500 Tablets:
Before and 2 hours after taking levofloxacin, patients should not use preparations containing divalent or trivalent cations. Examples include iron salts or antacids containing magnesium or aluminum, which can reduce absorption. The bioavailability of levofloxacin is significantly reduced when it is co-administered with sucralfate. Therefore, patients should take sucralfate only 2 hours after taking levofloxacin. In a clinical study, no pharmacokinetic interactions were found between levofloxacin and theophylline. However, the brain seizure threshold can be significantly reduced if quinolones are combined with theophylline, fenbufen or similar non-steroidal anti-inflammatory drugs or drugs that lower the seizure threshold. Patients should be cautious when co-administering levofloxacin with drugs that affect tubular secretion, eg probenecid and cimetidine, especially in patients with renal impairment. Increased clotting time (PT/INR), and major bleeding, have been observed and reported in patients treated with levofloxacin in combination with a vitamin K antagonist (eg, warfarin). Therefore, it is necessary to closely monitor blood clotting tests in patients treated with vitamin K antagonists. In addition, because foods and beverages contain many different types of active ingredients, they can affect or cause antagonism and synergism when the patient uses the drug. Therefore, patients should carefully read the instructions and consult a qualified doctor about taking Livran-500 Tablets with food, alcohol and tobacco.
To ensure drug quality, patients need to store Livran-500 Tablets in a dry place, away from direct light, children and family pets.
Livran-500 Tablets with the main ingredient is Levofloxacin belonging to the group of parasitic, antiviral, antifungal, and anti-infective drugs. Patients should carefully read the instructions in the medicine box, and consult with a doctor or specialist pharmacist before using it to ensure effective treatment, avoid side effects and dangerous drug interactions.
Follow Vinmec International General Hospital website to get more health, nutrition and beauty information to protect the health of yourself and your loved ones in your family.
Please dial HOTLINE for more information or register for an appointment HERE. Download MyVinmec app to make appointments faster and to manage your bookings easily.
